title: Should Patients with Hepatic Fibrosis Undergo LVAD Implantation: A Comparative Analysis.
abstract: The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% vs. 88.0%; p = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, p = 0.036).
authors.affiliation: From the *Wayne State University School of Medicine, Detroit, Michigan; †Division of Cardiothoracic Surgery, Henry Ford Hospital, Heart and Vascular Institute, Detroit, Michigan; and ‡Division of Cardiothoracic Transplant and Assist Devices, Texas Heart Institute, Baylor College of Medicine, Houston, Texas.
authors.forename: Linnea
authors.initials: L
authors.lastname: Xuereb
authors.forename: Pauline H
authors.initials: PH
authors.lastname: Go
authors.forename: Babbaljeet
authors.initials: B
authors.lastname: Kaur
authors.forename: Silvy
authors.initials: S
authors.lastname: Akrawe
authors.forename: Jamil
authors.initials: J
authors.lastname: Borgi
authors.forename: Gaetano
authors.initials: G
authors.lastname: Paone
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Morgan
mesh_terms: D000328:Adult; D000368:Aged; D006353:Heart-Assist Devices; D006801:Humans; D008103:Liver Cirrhosis / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis